Ensign Peak Advisors, Inc Astrazeneca PLC Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $115 Million - $129 Million	-1,865,991 Reduced 72.19%	718,682 $48.4 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $5.89 Million - $6.51 Million	90,818 Added 3.64%	2,584,673 $175 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $10.2 Million - $11.1 Million	145,938 Added 6.22%	2,493,855 $178 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $13.8 Million - $15.7 Million	218,959 Added 10.28%	2,347,917 $163 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $1.11 Million - $1.44 Million	20,454 Added 0.97%	2,128,958 $144 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $29.5 Million - $75.5 Million	-555,988 Reduced 20.87%	2,108,504 $116 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $15.8 Million - $18.9 Million	266,155 Added 11.1%	2,664,492 $176 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $85.9 Million - $103 Million	1,541,513 Added 179.91%	2,398,337 $159 Million
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $37.1 Million - $43.8 Million	686,697 Added 403.64%	856,824 $49.9 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $300,968 - $329,299	5,417 Added 3.29%	170,127 $10.2 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $823 - $1,023	17 Added 0.01%	164,710 $9.87 Million
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $484,851 - $559,697	-10,281 Reduced 5.88%	164,693 $8.19 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $8.49 Million - $10.2 Million	174,974 New	174,974 $8.75 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $9.82 Million - $11.3 Million	-185,065 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $7.43 Million - $9.54 Million	172,485 Added 1371.1%	185,065 $9.79 Million
Q1 2020 May 11, 2020	SELL	$37.79 - $51.33 $1.67 Million - $2.27 Million	-44,267 Reduced 77.87%	12,580 $562,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $2.41 Million - $2.87 Million	56,847 New	56,847 $2.83 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account